CRISPLD2 Antikörper
Kurzübersicht für CRISPLD2 Antikörper (ABIN5897702)
Target
Alle CRISPLD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Antigen Affinity Purified
-
-
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) (AA 31-58), (N-Term) antibody
CRISPLD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB26916 unconjugated
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) (N-Term) antibodyCRISPLD2 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) antibodyCRISPLD2 Reaktivität: Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) (AA 1-449) antibodyCRISPLD2 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) (AA 40-305) antibodyCRISPLD2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) (AA 140-430) antibodyCRISPLD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2) (N-Term) antibodyCRISPLD2 Reaktivität: Human, Ratte, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
- CRISPLD2 (Cysteine-Rich Secretory Protein LCCL Domain Containing 2 (CRISPLD2))
-
Andere Bezeichnung
- CRISPLD2
Target
-
